Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
menotropins
|
| gptkbp:approvedBy |
gptkb:FDA
2001 controlled ovarian stimulation |
| gptkbp:ATCCode |
G03GA02
|
| gptkbp:contains |
gptkb:luteinizing_hormone
follicle stimulating hormone |
| gptkbp:contraindication |
pregnancy
primary ovarian failure hypersensitivity to menotropins ovarian cysts not due to polycystic ovary syndrome uncontrolled thyroid or adrenal dysfunction |
| gptkbp:countryOfOperation |
gptkb:Australia
gptkb:Canada gptkb:United_Kingdom gptkb:United_States |
| gptkbp:form |
powder for solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Menopur
|
| gptkbp:indication |
infertility treatment
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Ferring_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
stimulates ovarian follicular growth
|
| gptkbp:pregnancyCategory |
X
|
| gptkbp:prescribes |
reproductive endocrinologist
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
abdominal pain
headache injection site reaction ovarian hyperstimulation syndrome |
| gptkbp:storage |
store at 25°C (77°F)
|
| gptkbp:usedFor |
assisted reproductive technology
ovulation induction |
| gptkbp:bfsParent |
gptkb:MRK
|
| gptkbp:bfsLayer |
5
|